Name: Global Biodegradable Devices for IBD Market Report [2035]
Creator: Roots Analysis
Published: 2025-02-28T00:00:01+05:30
License: https://www.rootsanalysis.com/privacy.html
Keywords: Biodegradable Devices for IBD Market, Biodegradable Devices for IBD Market Growth, Biodegradable Devices for IBD Market Trends, Biodegradable Devices for IBD Market Size, Biodegradable Devices for IBD Market Share, Biodegradable Devices for IBD Market Analysis, Biodegradable Devices for IBD Market Forecast, Biodegradable Devices for IBD Market Report, Global Biodegradable Devices for IBD Market, Biodegradable Devices for IBD Industry

Biodegradable Devices for IBD Market Overview

The global biodegradable devices for IBD market size, valued at USD 94 million in 2024, is projected to reach USD 114 million in 2025 and USD 799 million by 2035, representing a CAGR of 21.5% during the forecast period.

Biodegradable Devices for IBD Market Distribution by Type of Disease

Biodegradable Devices for IBD Market: In Summary

The global market for biodegradable devices for inflammatory bowel disease (IBD) is experiencing a significant growth, driven by the rising concern of inflammatory bowel diseases globally and side effects associated with conventionally available drugs.
Market players are greatly emphasizing the development of targeted drug delivery devices with higher biocompatibility, biodegradability, and efficacy in targeting diseases.
Technological innovations will remain the center focus for the market players, such as smart ingestible pills, 3D printing and nanotechnology. Moreover, industrial players are aiming to develop smart biomaterials which helps to deliver drug in controlled manner.
In terms of technology, the 3D printing segment is dominating the market driven by its increasing usage for design customized biodegradable stents and smart implants for IBD. However, the biohybrid / robotics segment is likely to witness a higher CAGR in the future.
In terms of material, the polylactic acid (PLA) segment is accounting for the highest share of the market, driven by its increasing usage for the development of drug delivery systems.
North America is currently dominating the market by securing nearly 60% of the overall revenue share. This highest share is due to the increasing research on the inflammatory bowel disease and devices for disease management.
Market players, such as Medtronic (Ireland), B. Braun (Germany) and Conmed (US) are aiming for technological innovations.
The future scope of this industry will be leveraging AI tools, personalized medicine, and smart implants / smart ingestible pills.

Biodegradable Devices for IBD Market Introduction

The global market for biodegradable devices for inflammatory bowel disease (IBD) is undergoing a transformative shift to meet the unmet clinical need. It is worth mentioning that the inflammatory bowel disease is a form of chronic inflammatory condition which affect gastrointestinal tract and leads to several complications. Notably, the most common inflammatory bowel diseases that are affecting global population are Crohn’s disease and ulcerative colitis.

While therapeutic treatment is available to manage this chronic inflammatory conditions, several limitations are still persisting, such as loss of response, non-responsive drugs, and side effects. These limitations are necessitating the demand for advance drug delivery devices that aims to deliver drugs at inflammation site for effective drug release. Biodegradable devices emerged as a promising solution to address the critical unmet need by allowing targeted drug release. These devices ensure prevention of premature drug clearance, reduce side effects and promote mucosal healing.

Unlock Deeper Insights – Schedule Your Personalized Workshop Today!

It is worth noting that several researchers are currently conducting clinical studies on biodegradable devices, smart ingestible pills, biosensors and smart technology that helps to proactive disease management with real-time data monitoring. In addition, the market players are focusing on biodegradable material innovations, leveraging 3D printing and nanotechnology to create a synergistic ecosystem where monitoring, diagnosing and treatment can be done continually. The ongoing clinical need and expanding research reflects a promising future of the biodegradable devise for IBD market.

Biodegradable Devices for IBD Market: Report Attributes

Key Report Attribute	Details
Historical Trend	Since 2020
Forecast Period	Till 2035
Market Size 2025	USD 114 Million
Market Size 2035	USD 799 Million
CAGR (Till 2035)	21.5%

One of the key objectives of the biodegradable device for IBD market report was to estimate the current size, opportunity, and the market growth potential, over the forecast period, till 2035. We have provided informed estimates on the likely evolution of the market for the forecast period.

The global biodegradable device for IBD market analysis also features the likely distribution of the current and forecasted opportunity within the market across various segments, such as type of product, type of technology, type of disease, type of material, application area, end user, geographical regions, and leading players.

In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of industry's evolution.

Recent Developments in Biodegradable Devices for IBD Market

Several recent developments in the field of biodegradable devices for IBD industry have occurred, and we have outlined some of these below:

In July 2025, a team of researchers have published study on the ingestible colorimetric ingestible pills known as pill for reactive oxygen species-responsive inflammation monitoring. This newly developed ingestible biosensor pill is designed to detect intestinal inflammation by measuring the reactive oxygen species, such as hydrogen peroxide. It is a non-invasive and patient-friendly device which will be used for monitoring inflammatory bowel disease.

In March 2025, Bionics Institute Chief Technology Officer, Prof James Fallon highlighted their researchers journey to find treatment for Crohn’s disease at the second Bionics Institute Preview Event. Prof. Fallon also updated about collaborators, institute supporters and broad members on the progress of research on vague nerve stimulation device to treat Crohn’s disease and epilepsy.

In June 2025, a protein based nanoparticle drug delivery systems (PNP-DDSs) shows promising outcome for the treatment of inflammatory bowel disease (IBD) by addressing several limitations of conventional therapies.

Would Like to Preview the Actual Report?

Biodegradable Devices for IBD Market Segmentation Insights

The market report presents an in-depth analysis of biodegradable devices for IBD providers who are currently active across various segments of the industry as mentioned below:

Biodegradable Devices for IBD Market: Market Segmentation

Market Segmentation	Details
Type of Product	Drug Delivery Systems Biodegradable Stents Sutures / Staples Surgical Meshes Implants & Patches Anti-Adhesive Tissue Barriers Wound Dressings Scaffolds Others
Type of Technology	3D Printing Nanotechnology Biohybrid / Robotics Capsule Endoscopy for IBD Diagnosis and Therapy
Type of Disease	Crohn’s Disease Ulcerative Colitis
Type of Material	Polylactic Acid (PLA) Polyglycolic Acid (PGA) Polycaprolactone (PCL) Polyhydroxyalkanoates (PHA) Others
Application Area	Inflammatory Bowel Disease (IBD) Treatment & Management Drug Delivery for IBD Other Applications
End User	Hospitals Ambulatory Surgical Centers Clinics Research and Academic Institutes
Geographical Regions	North America Europe Asia-Pacific Middle East & Africa Latin America
Market In North America	US Canada Mexico
Market In Europe	France Germany Italy Spain UK Rest of Europe
Market in Asia-Pacific	China India Japan South Korea New Zealand Rest of the Asia-Pacific
Market in Middle East & Africa	Egypt Iran Iraq Israel Saudi Arabia South Africa United Arab Emirates Rest of the Middle East & Africa
Market in Latin America	Argentina Brazil Rest of the Latin America

Industry Experts on Biodegradable Devices for IBD Market

Meanwhile, massive progress have been made to understand the inflammatory bowel disease and treatments. There is still scope of innovation to prevent disease, early intervention, and treatment to improve quality of life of patients with IBD.

During the IBD Innovate 2025 conference, Dr Andres Hurtado-Lorenzo (the Foundation’s Senior Vice President of Translational Research & IBD Ventures) stated that, “IBD Innovate unites leaders from science, medicine, and industry, alongside patients and advocates, to foster partnerships and convert knowledge to accelerate the development of next generation therapies and devices that improve the lives of people living with IBD”.

Market Share by Type of Product: Do Drug Delivery Systems Holds a Promising Future in the Market?

Based on the type of product, the global market is segmented into drug delivery systems, biodegradable stents, sutures / staples, surgical meshes, implants & patches, anti-adhesive, tissue barriers, wound dressings, scaffolds, and others. According to our projection, the drug delivery systems segment is dominating the biodegradable devices for IBD market. This can be attributed to the growing demand for advanced drug delivery devices that can cross gastrointestinal physiological barriers for targeted drug delivery.
In the long run, biodegradable stents segment is likely to show lucrative growth at the highest CAGR. The heightened demand for biodegradable stents for IBD management is likely to be a key factor for robust growth of this segment in the future.

Market Share by Type of Technology: How Does 3D printing is Benefitting the Biodegradable Device Development?

The global market is differentiated across different type of technology, such as 3D Printing, nanotechnology, biohybrid / robotics, and capsule endoscopy for IBD diagnosis and therapy. According to the biodegradable devices for IBD market report, the 3D printing segment is dominating the market, driven by its ability to print customize implants for treating inflammatory bowel disease.
It is worth noting that the biohybrid / robotics segment is likely to bolster at a higher CAGR in the future. Notably, the biohybrid / robotics is an emerging trend in the industry. Currently, several researches are undergoing on micro robotic pills which has shown promising outcomes of IBD treatment in animal models.

Market Share by Type of Disease: Do Crohn’s Disease Segment Hold the Highest Share in the Future?

The global market is categorized across different type of disease, such as Crohn’s disease, and ulcerative colitis. According to the biodegradable devices for IBD market forecast, the Crohn’s disease segment is accounting for more than 60% of the market share. This dominance stems from the increasing prevalence of Crohn’s disease and surge in the demand for minimally invasive procedures to treat patient to address the complications associated with disease, such as fistulas and strictures.
In the long run, the ulcerative colitis segment is likely to grow at the fastest CAGR during the forecast period. There is a significant research initiatives are currently being undertaking to develop treatment for ulcerative colitis. This ongoing research and rise in the surge of ulcerative colitis is key a factor for lucrative share of this segment.

Have Questions? Let's Get Them Answered

Market Share by Type of Material: Which Biodegradable Polymers for IBD Therapy Will Dominate the Market?

This segment highlights the distribution of global market across different type of material, such as polylactic acid (PLA), polyglycolic acid (PGA), polycaprolactone (PCL), polyhydroxyalkanoates (PHA), and others. According to our analysis, the polylactic acid (PLA) segment is dominating the market. Notably, the polyglycolic acid material is widely used in drug delivery systems to its high biocompatibility and stability.
Owing to its widespread adoption for clinical use, polyglycolic acid is likely to remain dominant and grow at a higher CAGR during the forecast period.

Market Share by Application Area: Which Application Area Hold the Highest Share of the Market?

The global market is sub-segmented based on application area into inflammatory bowel disease (IBD) treatment & management, drug delivery for IBD, and other applications. According to the biodegradable devices for IBD market forecast, the inflammatory bowel disease (IBD) treatment & management segment is dominating the market, driven by the rising prevalence of disease.
It is important to note here that this segment will continue to dominate in the future and is expected to grow at a higher CAGR. This lucrative growth is due to the promising outcomes of biodegradable devices for IBD in clinical studies and high demand for targeted drug delivery solutions to manage disease.

Market Share by End User: Will Clinics and Research Dominate in the Future?

Based on the end user, the global market is segmented into hospitals, ambulatory surgical centers, clinics and research and academic institutes. According to the biodegradable IBD devices industry analysis, the hospitals segment is dominating the market by holding largest biodegradable devices for IBD market share. This is potentially due to the increasing adoption of sustained-release biodegradable IBD systems for treating wide pool of IBD patients in hospitals.
It is worth noting that the ambulatory surgical centers segment is likely to grow at the fastest CAGR in the future. The patient safety benefits from using biodegradable materials in IBD surgical interventions is likely to increase the demand of these materials for ambulatory surgical centers.

Regional Dynamics: Which Region is Expected to Dominate the Market?

The global market is distributed into North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America. According to our projection, the North America is dominating the market, accounting for the highest share (nearly 60%) of the biodegradable devices for IBD market growth. This highest share stems from the rising prevalence of inflammatory bowel disease, healthcare infrastructure advancements and significant research on biodegradable devices to treat patients.
The Asia-Pacific region is likely to show robust growth, anticipating registering higher CAGR in the future. Several factors, such as rising concern of IBD and increasing expenditure on healthcare infrastructure to treat patients with a personalized approach.

Biodegradable Devices for IBD Market: Report Deliverables

Report Deliverables	Details
Excel Data Packs (Complimentary)	Market Landscape Company Competitiveness Analysis Startup Ecosystem in the Market Patent Analysis Partnership and Collaborations Analysis Grant Analysis Funding and Investment Analysis Market Forecast and Opportunity Analysis
Key Biodegradable Devices for IBD Companies Profiled	Arthrex (US) Aesculap Implant Systems (US) Bioretec (Finland) B. Braun (Germany) Conmed (US) Exactech (US) Integra Life Sciences (US) Medtronic (Ireland) Nu Vasive (US) Orthofix Medical (US) Osteomed (US) Stryker (US) Smith and Nephew (UK) Wright Medical (US) (A complete list of companies captured is available in the report)
PowerPoint Presentation (Complimentary)	Available
Customization Scope	15% Free Customization

Biodegradable Devices for IBD Market Key Takeaways

The "Biodegradable Devices for IBD Market Report: Industry Trends and Global Forecasts, till 2035" market report features an extensive study of the current market landscape, and future opportunities for market players. The market research report lays emphasis on the biodegradable devices for IBD that are being developed to treat patients. Key takeaways of the market report are briefly discussed below.

Market Competitive Landscape: What Factors are Making Biodegradable Devices for IBD Market Competitive?

The global biodegradable devices for IBD industry is moderately competitive, featuring the presence of small, mid-sized and large companies. In order to leverage the competitive edge, several market players are undertaking strategic initiatives to advance materials and technologies, such as biodegradable polymers for IBD therapy. Moreover, the market players are also expanding partnerships and collaborations, which is expected to maintain a long-term competitiveness in the industry.

Market Size Analysis: What will be the Biodegradable Devices for IBD Market Size in 2035?

The global market for biodegradable devices for IBD is poised to reach USD 799 million by 2035. This lucrative growth stems from the positive clinical outcomes of implantable biodegradable devices in Crohn's disease management. According to the study published in ScienceDirect, biodegradable microspheres and nanoparticles have shown promising outcomes in delivering therapeutic drugs, such as budesonide and dexamethasone in preclinical studies, leads to reduce gut inflammation that occur due to inflammatory bowel disease and enhance tissue healing in animal models. These promising results in clinical studies, indicating that the industry is progressing and growing rapidly.

Get an Instant Quote in 10 Minutes. Lowest Price Guaranteed

Market Drivers: What Factors are Driving Biodegradable Devices for IBD Market Growth?

Notably, the IBD diseases, such as ulcerative colitis and Crohn’s disease require target specific therapeutics and medical device or disease management. The increasing prevalence of gastrointestinal diseases is likely to propel the demand for biodegradable devices for IBD management. Some other potential interconnected factors of market growth are listed below:

Demand for Minimal Invasive Devices for Disease Treatment

Inflammatory bowel disease is a debilitating disease. It is characterized by remission and period of flare-ups. The traditional approach have to pass through entire digestive systems, and some patients may require IBD-related surgeries, such as colectomies for implementing drug releasing implants and removal implants. The invasive nature and requirement of second surgeries has necessitated the demand for minimal invasive biodegradable devices. These devices eliminate the requirement of second surgery because it get dissolved into the body after some time, thereby creating a massive demand for disease management.

Expanding Research on Advanced Materials and Device Designs

Market players are continually focusing on biomaterials innovation to develop more reliable, efficient and customizable biodegradable devices for IBD. Additionally, emerging technologies, such as 3D printing, help in designing customized bioabsorbable implants for inflammatory bowel disease. It is worth noting that the industrial players are also focusing on nanoparticles for biodegradable devices that enable controlled drug release and enhance mechanical strength. These key innovations are likely to expand the market in the future.

Market Challenges: What Barriers Limit Scale-Up Manufacturing Biodegradable IBD Devices?

The market witness several barriers to commercializing biodegradable IBD medical devices in healthcare systems. Some of the potential challenges are listed below:

Targeted Drug Delivery and Efficacy

Inflammatory bowel disease is characterized by inflammation in the gastrointestinal tract. The prolong inflammation can cause pH variation in the gastrointestinal tract. Additionally, the multiple physiological barriers of the gastrointestinal tract further create difficulty in release drug at targeted sites through medical devices. Therefore, biodegradable devices must be engineered to overcome these obstacles and allow for effective drug penetration and absorption.

Complex Regulatory Pathways for Biodegradable Drug Delivery Systems Targeting Inflammatory Bowel Disease

Biodegradable devices require clinical validation to demonstrate safety and efficacy to treat inflammatory bowel disease. Given by the complex of IBD and requirement of long term monitoring, regulatory authorities have stringent guidelines, which may create challenges for the market players. Moreover, meeting regulatory standards require clinical validation documents which is an extensive and expensive process. These complexities associated with regulatory approval are significant barriers for the market players.

Market Trends: What are the Future Biodegradable Devices for IBD Market Trends?

Shift Towards Smart Biodegradable Devices for IBD Monitoring

One of the significant trend to be noticed in the market is shift towards smart implantable biodegradable drug delivery systems. These smart implants ensure non-invasive monitoring and provide real-time data about physiological changes for disease management. Moreover, the market players are aiming to develop smart ingestible pills to deliver therapeutics to inflamed colonic tissues. These smart devices also help to detect inflammation biomarkers by using engineered bacteria that enable healthcare personnel to manage disease proactively.

Personalized Biomarker-Guided Therapy for Mucosal Healing

Owing to the ongoing concern of inflammatory bowel disease, the market players are emphasizing shifting from one-size-fit-all approach to personalized medicine. This approach will involve biomarker guided therapy to heal mucosal wall damage that occur due to inflammation. The personalized medicine approach will also include multi-omics data analysis for biomarker discovery to guide therapy optimization for maximum efficiency of treatment.

Biodegradable Devices for IBD Market Report Coverage

The market report presents an in-depth analysis, highlighting the capabilities of various stakeholders in the biodegradable devices for IBD industry, across different geographies. Amongst other elements, the market report includes:

An Infographic Executive Summary
Regulatory Scenario
Comprehensive Database of Leading Players
Competitive Landscape
Company Competitiveness Analysis
Startup Ecosystem in the Biodegradable Devices for IBD Market
Company Profiles
Porter’s Five Forces Analysis
Patent Analysis
Partnerships and Collaborations
Grant Analysis
Funding and Investment Analysis
Clinical Trial Analysis
Market Forecast and Opportunity Analysis
Adjacent Market Analysis
Key Winning Strategies
SWOT Analysis

Glossary

Biocompatibility: This refers to the ability of a material to perform with an appropriate host response in a specific application. It means the material does not cause harmful or undesirable reactions in the body.
Biodegradable Devices: Medical devices manufactured from materials designed to degrade or dissolve safely and independently within the body over a specific period after serving their functional purpose, eliminating the need for surgical removal.
Biomarkers: Measurable indicators of a biological state or condition. In IBD, biomarkers can indicate inflammation, disease activity, or treatment response (e.g., C-reactive protein, fecal calprotectin).
Biosensor: It is form of sensor device that detects, records, and transmits information regarding a biological change or process. In case of inflammatory bowel disease, these biosensors can monitor inflammatory markers.

From the Author’s Desk

Author’s View on Biodegradable Devices for IBD Market

The global biodegradable devices for IBD market is witnessing a robust growth trajectory and the market will continue to grow in the future. Some notable drivers, such as demand for minimally invasive procedures, and multi-disciplinary innovations to treat patients with inflammatory bowel diseases are propelling the market in the future. Experts in gastroenterology, biomaterials science, and the medical device industry largely concur that these devices represent a significant paradigm shift in IBD management. The current scenario reflects increasing research and clinical trials by market players and research organizations on next-generation biodegradable devices with integrated biosensors. However, the future, The focus will increasingly be on creating personalized, integrated solutions that combine diagnostics, targeted therapeutics, and long-term monitoring, ultimately enhancing the quality of life for IBD patients.

Customization Opportunities

At Roots Analysis, we genuinely care about your success and understand that your business requirements are unique. While our market research reports provide valuable insights, we recognize that they might not cover every aspect you need to make well-informed strategic decisions. To account for that, we offer 15% free report customization tailored to your specific needs. Whether you require additional quantitative analysis, qualitative insights, or any other information related to the electric vehicles market, reach out to us today at support@rootsanalysis.com

+ 1. PREFACE

1.1. Introduction

1.2. Market Share Insights

1.3. Key Market Insights

1.4. Report Coverage

1.5. Key Questions Answereds

1.6. Chapter Outlines

+ 2. RESEARCH METHODOLOGY

2.1. Chapter Overview

2.2. Research Assumptions

2.3. Database Building

2.3.1. Data Collection

2.3.2. Data Validation

2.3.3. Data Analysis

2.4. Project Methodology

2.4.1. Secondary Research

2.4.1.1. Annual Reports

2.4.1.2. Academic Research Papers

2.4.1.3. Company Websites

2.4.1.4. Investor Presentations

2.4.1.5. Regulatory Filings

2.4.1.6. White Papers

2.4.1.7. Industry Publications

2.4.1.8. Conferences and Seminars

2.4.1.9. Government Portals

2.4.1.10. Media and Press Releases

2.4.1.11. Newsletters

2.4.1.12. Industry Databases

2.4.1.13. Roots Proprietary Databases

2.4.1.14. Paid Databases and Sources

2.4.1.15. Social Media Portals

2.4.1.16. Other Secondary Sources

2.4.2. Primary Research

2.4.2.1. Introduction

2.4.2.2. Types

2.4.2.2.1. Qualitative

2.4.2.2.2. Quantitative

2.4.2.3. Advantages

2.4.2.4. Techniques

2.4.2.4.1. Interviews

2.4.2.4.2. Surveys

2.4.2.4.3. Focus Groups

2.4.2.4.4. Observational Research

2.4.2.4.5. Social Media Interactions

2.4.2.5. Stakeholders

2.4.2.5.1. Company Executives (CXOs)

2.4.2.5.2. Board of Directors

2.4.2.5.3. Company Presidents and Vice Presidents

2.4.2.5.4. Key Opinion Leaders

2.4.2.5.5. Research and Development Heads

2.4.2.5.6. Technical Experts

2.4.2.5.7. Subject Matter Experts

2.4.2.5.8. Scientists

2.4.2.5.9. Doctors and Other Healthcare Providers

2.4.2.6. Ethics and Integrity

2.4.2.6.1. Research Ethics

2.4.2.6.2. Data Integrity

2.4.3. Analytical Tools and Databases

+ 3. MARKET DYNAMICS

3.1. Forecast Methodology

3.1.1. Top-Down Approach

3.1.2. Bottom-Up Approach

3.1.3. Hybrid Approach

3.2. Market Assessment Framework

3.2.1. Total Addressable Market (TAM)

3.2.2. Serviceable Addressable Market (SAM)

3.2.3. Serviceable Obtainable Market (SOM)

3.2.4. Currently Acquired Market (CAM)

3.3. Forecasting Tools and Techniques

3.3.1. Qualitative Forecasting

3.3.2. Correlation

3.3.3. Regression

3.3.4. Time Series Analysis

3.3.5. Extrapolation

3.3.6. Convergence

3.3.7. Forecast Error Analysis

3.3.8. Data Visualization

3.3.9. Scenario Planning

3.3.10. Sensitivity Analysis

3.4. Key Considerations

3.4.1. Demographics

3.4.2. Market Access

3.4.3. Reimbursement Scenarios

3.4.4. Industry Consolidation

3.5. Robust Quality Control

3.6. Key Market Segmentations

3.7. Limitations

+ 4. MACRO-ECONOMIC INDICATORS

4.1. Chapter Overview

4.2. Market Dynamics

4.2.1. Time Period

4.2.1.1. Historical Trends

4.2.1.2. Current and Forecasted Estimates

4.2.2. Currency Coverage

4.2.2.1. Overview of Major Currencies Affecting the Market

4.2.2.2. Impact of Currency Fluctuations on the Industry

4.2.3. Foreign Exchange Impact

4.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market

4.2.3.2. Strategies for Mitigating Foreign Exchange Risk

4.2.4. Recession

4.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt

4.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market

4.2.5. Inflation

4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy

4.2.5.2. Potential Impact of Inflation on the Market Evolution

4.2.6. Interest Rates

4.2.6.1. Overview of Interest Rates and Their Impact on the Market

4.2.6.2. Strategies for Managing Interest Rate Risk

4.2.7. Commodity Flow Analysis

4.2.7.1. Type of Commodity

4.2.7.2. Origins and Destinations

4.2.7.3. Values and Weights

4.2.7.4. Modes of Transportation

4.2.8. Global Trade Dynamics

4.2.8.1. Import Scenario

4.2.8.2. Export Scenario

4.2.9. War Impact Analysis

4.2.9.1. Russian-Ukraine War

4.2.9.2. Israel-Hamas War

4.2.10. COVID Impact / Related Factors

4.2.10.1. Global Economic Impact

4.2.10.2. Industry-specific Impact

4.2.10.3. Government Response and Stimulus Measures

4.2.10.4. Future Outlook and Adaptation Strategies

4.2.11. Other Indicators

4.2.11.1. Fiscal Policy

4.2.11.2. Consumer Spending

4.2.11.3. Gross Domestic Product (GDP)

4.2.11.4. Employment

4.2.11.5. Taxes

4.2.11.6. R&D Innovation

4.2.11.7. Stock Market Performance

4.2.11.8. Supply Chain

4.2.11.9. Cross-Border Dynamics

+ 5. EXECUTIVE SUMMARY

+ 6. INTRODUCTION

6.1. Chapter Overview

6.2. Overview of Biodegradable Devices for IBD

6.2.1. Role of Biodegradable Devices for IBD

6.2.2. Advantages of Biodegradable Devices for IBD

6.2.3. Challenges Associated with Biodegradable Devices for IBD

6.3. Future Perspective

+ 7. REGULATORY SCENARIO

+ 8. COMPREHENSIVE DATABASE OF LEADING PLAYERS

+ 9. COMPETITIVE LANDSCAPE

9.1. Chapter Overview

9.2. Biodegradable Devices for IBD: Overall Market Landscape

9.2.1. Analysis by Year of Establishment

9.2.2. Analysis by Company Size

9.2.3. Analysis by Location of Headquarters

9.2.4. Biodegradable Devices for IBD: Overall Market Landscape

9.2.4.1. Analysis by Product Type

9.2.4.2. Analysis by Technology Type

9.2.4.3. Analysis by Disease Type

9.2.4.4. Analysis by Material Type

9.2.4.5. Analysis by Application Area

9.2.4.6. Analysis by End User

+ 10. COMPETITIVE COMPETITIVENESS ANALYSIS

+ 11. STARTUP ECOSYSTEM IN THE BIODEGRADABLE DEVICES IBD MARKET

11.1. Biodegradable Devices for IBD: Market Landscape of Startups

11.1.1. Analysis by Year of Establishment

11.1.2. Analysis by Company Size

11.1.3. Analysis by Company Size and Year of Establishment

11.1.4. Analysis by Location of Headquarters

11.1.5. Analysis by Company Size and Location of Headquarters

11.1.6. Analysis by Ownership Structure

11.2. Key Findings

+ 12. COMPANY PROFILES

12.1. Chapter Overview

12.2. Arthrex (US)

12.2.1. Company Overview

12.2.2. Company Mission

12.2.3. Company Footprint

12.2.4. Management Team

12.2.5. Contact Details

12.2.6. Financial Performance

12.2.7. Operating Business Segments

12.2.8. Pipeline Portfolio

12.2.9. MOAT Analysis

12.2.10. Recent Developments and Future Outlook

* similar detail is presented for other below mentioned companies based on information in the public domain

12.3. Aesculap Implant Systems (US)

12.4. Bioretec (Finland)

12.5. B. Braun (Germany)

12.6. Conmed (US)

12.7. Exactech (US)

12.8. Integra Life Sciences (US)

12.9. Medtronic (Ireland)

12.10. Nu Vasive (US)

12.11. Orthofix Medical (US)

12.12. Osteomed (US)

12.13. Stryker (US)

12.14. Smith and Nephew (UK)

12.15. Wright Medical (US)

+ 13. PORTER'S FIVE FORCES ANALYSIS

+ 14. PATENT ANALYSIS

14.1. Chapter Overview

14.2. Scope and Methodology

14.3. Biodegradable Devices for IBD: Patent Analysis

14.3.1. Analysis by Patent Publication Year

14.3.2. Analysis by Type of Patent and Patent Publication Year

14.3.3. Analysis by Patent Application Year

14.3.4. Analysis by Patent Jurisdiction

14.3.5. Analysis by CPC Symbols

14.3.6. Analysis by Type of Applicant

14.3.7. Leading Industry Players: Analysis by Number of Patents

14.3.8. Leading Individual Assignees: Analysis by Number of Patents

+ 15. PARTNERSHIPS AND COLLABORATIONS

15.1. Chapter Overview

15.2. Partnership Models

15.3. Biodegradable Devices for IBD: Partnerships and Collaborations

15.3.1. Analysis by Year of Partnership

15.3.2. Analysis by Type of Partnership

15.3.3. Analysis by Year and Type of Partnership

15.3.4. Analysis by Type of Partner

15.3.5. Analysis by Location of Headquarters of Partner

15.3.6. Analysis by Type of Partnership and Location of Headquarters of Partner

15.3.7. Most Active Players: Analysis by Number of Partnerships

15.3.8. Regional Analysis

15.3.8.1. Intercontinental and Intracontinental Deals

15.3.8.2. Local and International Deals

+ 16. GRANT ANALYSIS

16.1. Chapter Overview

16.2. Scope and Methodology

16.3. Biodegradable Devices for IBD: Grant Analysis

16.3.1. Analysis by Year of Grant Award

16.3.2. Analysis by Amount Awarded

16.3.3. Analysis by Support Period

16.3.4. Analysis by Support Period and Funding Institute Center

16.3.5. Analysis by Type of Grant Application

16.3.6. Analysis by Purpose of Grant Award

16.3.7. Analysis By Activity Code

16.3.8. Analysis by NIH Spending Category

16.3.9. Analysis by Study Section Involved

16.3.10. Popular NIH Departments: Analysis by Number of Grants

16.3.11. Analysis by Type of Recipient Organization

16.3.12. Prominent Program Officers: Analysis by Number of Grants

16.3.13. Popular Recipient Organizations: Analysis by Number of Grants

16.3.14. Popular Recipient Organizations: Analysis by Grant Amount

16.3.15. Analysis by Region of Recipient Organizations

+ 17. FUNDING AND INVESTMENTS ANALYSIS

17.1. Funding Models

17.2. Biodegradable Devices for IBD: Funding and Investments

17.2.1. Analysis by Year of Funding

17.2.2. Analysis of Funding Instances by Type of Funding

17.2.3. Analysis of Funding Instances by Year and Type of Funding

17.2.4. Analysis of Amount Invested by Type of Funding

17.2.5. Analysis of Funding Instances by Country

17.2.6. Most Active Players: Analysis by Amount Raised

17.3. Summary and Key Takeaways

+ 18. CLINICAL TRIAL ANALYSIS

18.1. Analysis Methodology and Key Parameters

18.2. Biodegradable Devices for IBD: Clinical Trial Analysis

18.2.1. Analysis by Trial Status

18.2.2. Analysis by Trial Registration Year

18.2.3. Analysis by Type of Sponsor / Collaborator

18.2.4. Analysis by Type of Study Design

18.2.5. Analysis by Registration Year and Type of Study

18.2.6. Analysis by Patient Enrollment

18.2.7. Year-wise Trend of Completed and Recruiting Trials

18.2.8. Analysis by Age Category

18.2.9. Word Cloud of Study Titles

18.2.10. Most Active Industry Players: Analysis by Number of Registered Trials

18.2.11. Most Active Non- Industry Players: Analysis by Number of Registered Trials

18.2.12. Analysis by Trial Location

18.2.13. Analysis by Trial Status and Geography

+ 19. GLOBAL BIODEGRADABLE DEVICES FOR IBD MARKET

19.1. Chapter Overview

19.2. Key Assumptions and Methodology

19.3. Trends Disruption Impacting Market

19.4. Demand Side Trends

19.5. Supply Side Trends

19.6. Global Biodegradable Devices for IBD Market, Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

19.7. Multivariate Scenario Analysis

19.7.1. Conservative Scenario

19.7.2. Optimistic Scenario

19.8. Investment Feasibility Index

19.9. Key Market Segmentations

+ 20. MARKET OPPORTUNITIES BASED ON TYPE OF PRODUCT

20.1. Chapter Overview

20.2. Key Assumptions and Methodology

20.3. Revenue Shift Analysis

20.4. Market Movement Analysis

20.5. Penetration-Growth (P-G) Matrix

20.6. Biodegradable Devices for IBD Market for Drug Delivery Systems: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

20.7. Biodegradable Devices for IBD Market for Biodegradable Stents: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

20.8. Biodegradable Devices for IBD Market for Sutures / Staples: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

20.9. Biodegradable Devices for IBD Market for Surgical Meshes: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

20.10. Biodegradable Devices for IBD Market for Implants & Patches: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

20.11. Biodegradable Devices for IBD Market for Anti-Adhesive: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

20.12. Biodegradable Devices for IBD Market for Tissue Barriers: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

20.13. Biodegradable Devices for IBD Market for Wound Dressings: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

20.14. Biodegradable Devices for IBD Market for Scaffolds: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

20.15. Biodegradable Devices for IBD Market for Tissue Barriers: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

20.16. Biodegradable Devices for IBD Market for Others: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

20.17. Data Triangulation and Validation

20.17.1. Secondary Sources

20.17.2. Primary Sources

20.17.3. Statistical Modeling

+ 21. MARKET OPPORTUNITIES BASED ON TYPE OF TECHNOLOGY

21.1. Chapter Overview

21.2. Key Assumptions and Methodology

21.3. Revenue Shift Analysis

21.4. Market Movement Analysis

21.5. Penetration-Growth (P-G) Matrix

21.6. Biodegradable Devices for IBD Market for 3D Printing: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

21.7. Biodegradable Devices for IBD Market for Nanotechnology: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

21.8. Biodegradable Devices for IBD Market for Biohybrid / Robotics: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

21.9. Biodegradable Devices for IBD Market for Capsule Endoscopy for IBD Diagnosis and Therapy: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

21.10. Data Triangulation and Validation

21.10.1. Secondary Sources

21.10.2. Primary Sources

21.10.3. Statistical Modeling

+ 22. MARKET OPPORTUNITIES BASED ON TYPE OF DISEASE

22.1. Chapter Overview

22.2. Key Assumptions and Methodology

22.3. Revenue Shift Analysis

22.4. Market Movement Analysis

22.5. Penetration-Growth (P-G) Matrix

22.6. Biodegradable Devices for IBD Market for Crohn's Disease: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

22.7. Biodegradable Devices for IBD Market for Ulcerative Colitis: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

22.8. Data Triangulation and Validation

22.8.1. Secondary Sources

22.8.2. Primary Sources

22.8.3. Statistical Modeling

+ 23. MARKET OPPORTUNITIES BASED ON TYPE OF MATERIAL

23.1. Chapter Overview

23.2. Key Assumptions and Methodology

23.3. Revenue Shift Analysis

23.4. Market Movement Analysis

23.5. Penetration-Growth (P-G) Matrix

23.6. Biodegradable Devices for IBD Market for Polylactic Acid (PLA): Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

23.7. Biodegradable Devices for IBD Market for Polyglycolic Acid (PGA): Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

23.8. Biodegradable Devices for IBD Market for Polycaprolactone (PCL): Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

23.9. Biodegradable Devices for IBD Market for Polyhydroxyalkanoates (PHA): Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

23.10. Biodegradable Devices for IBD Market for Others: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

23.11. Data Triangulation and Validation

23.11.1. Secondary Sources

23.11.2. Primary Sources

23.11.3. Statistical Modeling

+ 24. MARKET OPPORTUNITIES BASED ON APPLICATION AREA

24.1. Chapter Overview

24.2. Key Assumptions and Methodology

24.3. Revenue Shift Analysis

24.4. Market Movement Analysis

24.5. Penetration-Growth (P-G) Matrix

24.6. Biodegradable Devices for IBD Market for Inflammatory Bowel Disease (IBD) Treatment: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

24.7. Biodegradable Devices for IBD Market for Drug Delivery for IBD: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

24.8. Biodegradable Devices for IBD Market for Other Applications: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

24.9. Data Triangulation and Validation

24.9.1. Secondary Sources

24.9.2. Primary Sources

24.9.3. Statistical Modeling

+ 25. MARKET OPPORTUNITIES BASED ON END USER

25.1. Chapter Overview

25.2. Key Assumptions and Methodology

25.3. Revenue Shift Analysis

25.4. Market Movement Analysis

25.5. Penetration-Growth (P-G) Matrix

25.6. Biodegradable Devices for IBD Market for Hospitals: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

25.7. Biodegradable Devices for IBD Market for Ambulatory Surgical Centers: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

25.8. Biodegradable Devices for IBD Market for Clinics: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

25.9. Biodegradable Devices for IBD Market for Research and Academic Institutes: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

25.10. Data Triangulation and Validation

25.10.1. Secondary Sources

25.10.2. Primary Sources

25.10.3. Statistical Modeling

+ 26. MARKET OPPORTUNITIES FOR BIODEGRADABLE DEVICES FOR IBD IN NORTH AMERICA

26.1. Chapter Overview

26.2. Key Assumptions and Methodology

26.3. Revenue Shift Analysis

26.4. Market Movement Analysis

26.5. Penetration-Growth (P-G) Matrix

26.6. Biodegradable Devices for IBD Market in North America: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

26.6.1. Biodegradable Devices for IBD Market in the US: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

26.6.2. Biodegradable Devices for IBD Market in Canada: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

26.6.3. Biodegradable Devices for IBD Market in Mexico: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

26.7. Data Triangulation and Validation

+ 27. MARKET OPPORTUNITIES FOR BIODEGRADABLE DEVICES FOR IBD IN EUROPE

27.1. Chapter Overview

27.2. Key Assumptions and Methodology

27.3. Revenue Shift Analysis

27.4. Market Movement Analysis

27.5. Penetration-Growth (P-G) Matrix

27.6. Biodegradable Devices for IBD Market in Europe: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

27.6.1. Biodegradable Devices for IBD Market in France: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

27.6.2. Biodegradable Devices for IBD Market in Italy: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

27.6.3. Biodegradable Devices for IBD Market in Germany: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

27.6.4. Biodegradable Devices for IBD Market in Spain: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

27.6.5. Biodegradable Devices for IBD Market in the UK: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

27.6.6. Biodegradable Devices for IBD Market in Rest of the Europe: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

27.7. Data Triangulation and Validation

+ 28. MARKET OPPORTUNITIES FOR BIODEGRADABLE DEVICES FOR IBD IN ASIA-PACIFIC

28.1. Chapter Overview

28.2. Key Assumptions and Methodology

28.3. Revenue Shift Analysis

28.4. Market Movement Analysis

28.5. Penetration-Growth (P-G) Matrix

28.6. Biodegradable Devices for IBD Market in Asia-Pacific: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

28.6.1. Biodegradable Devices for IBD Market in China: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

28.6.2. Biodegradable Devices for IBD Market in India: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

28.6.3. Biodegradable Devices for IBD Market in Japan: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

28.6.4. Biodegradable Devices for IBD Market in South Korea: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

28.6.5. Biodegradable Devices for IBD Market in New Zealand: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

28.6.6. Biodegradable Devices for IBD Market in Rest of the Asia-Pacific: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

28.7. Data Triangulation and Validation

+ 29. MARKET OPPORTUNITIES FOR BIODEGRADABLE DEVICES FOR IBD IN MIDDLE EAST AND AFRICA (MEA)

29.1. Chapter Overview

29.2. Key Assumptions and Methodology

29.3. Revenue Shift Analysis

29.4. Market Movement Analysis

29.5. Penetration-Growth (P-G) Matrix

29.6. Biodegradable Devices for IBD Market in Middle East and Africa (MEA): Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

29.6.1. Biodegradable Devices for IBD Market in Egypt: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

29.6.2. Biodegradable Devices for IBD Market in Iran: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

29.6.3. Biodegradable Devices for IBD Market in Iraq: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

29.6.4. Biodegradable Devices for IBD Market in Israel: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

29.6.5. Biodegradable Devices for IBD Market in Saudi Arabia: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

29.6.6. Biodegradable Devices for IBD Market in South Africa: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

29.6.7. Biodegradable Devices for IBD Market in United Arab Emirates: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

29.7. Data Triangulation and Validation

+ 30. MARKET OPPORTUNITIES FOR BIODEGRADABLE DEVICES FOR IBD IN LATIN AMERICA

30.1. Chapter Overview

30.2. Key Assumptions and Methodology

30.3. Revenue Shift Analysis

30.4. Market Movement Analysis

30.5. Penetration-Growth (P-G) Matrix

30.6. Biodegradable Devices for IBD Market in Latin America: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

30.6.1. Biodegradable Devices for IBD Market in Argentina: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

30.6.2. Biodegradable Devices for IBD Market in Brazil: Historical Trends (Since 2020) and Forecasted Estimates (Till 2035)

30.7. Data Triangulation and Validation

+ 31. KEY WINNING STRATEGIES

+ 32. SWOT ANALYSIS

+ 33. ROOTS STRATEGIC RECOMMENDATIONS

+ 34. INSIGHTS FROM PRIMARY RESEARCH

+ 35. REPORT CONCLUSION

+ 36. TABULATED DATA

+ 37. LIST OF COMPANIES AND ORGANIZATIONS

+ 38. CUSTOMIZATION OPPORTUNITIES

+ 39. ROOTS SUBSCRIPTION SERVICES

+ 40. AUTHOR DETAILS

Biodegradable Devices for IBD Market